Specialty pharmaceutical company PharmaTher Holdings’ drug application for Ketamine has received a June 4 approval goal date, advancing approval of the drug in the U.S. PharmaTher said it is ...

Ketamine is an incredible molecule, capable of alleviating treatment-resistant depression as well as facilitating psychological breakthroughs. However, due to a lack of regulation and capitalist ...

Ketamine has been around for decades but has been having a resurgence in recent years as an option for people with treatment-resistant depression. Loosened regulations around remote prescriptions ...